HomeBBIO • NASDAQ
add
BridgeBio Pharma Inc
Previous close
$34.90
Day range
$32.32 - $35.00
Year range
$21.68 - $39.47
Market cap
6.24B USD
Avg Volume
3.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 5.88M | 237.08% |
Operating expense | 225.13M | 26.61% |
Net income | -265.05M | -57.63% |
Net profit margin | -4.51K | 53.24% |
Earnings per share | -1.37 | -43.24% |
EBITDA | -219.97M | -25.64% |
Effective tax rate | -0.43% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 681.10M | 56.62% |
Total assets | 919.34M | 68.26% |
Total liabilities | 2.38B | 25.84% |
Total equity | -1.46B | — |
Shares outstanding | 190.19M | — |
Price to book | -4.52 | — |
Return on assets | -69.85% | — |
Return on capital | -141.10% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -265.05M | -57.63% |
Cash from operations | -195.33M | -56.49% |
Cash from investing | -3.24M | -4,804.55% |
Cash from financing | 473.93M | 10,578.24% |
Net change in cash | 275.37M | 312.79% |
Free cash flow | 31.53M | 169.59% |
About
CEO
Founded
2015
Headquarters
Website
Employees
728
